Exosomes As a Therapeutic Tool to Promote Neurorestoration and Cognitive Function in Neurological Conditions: Achieve Two Ends with a Single Effort

Overview

Journal CNS Neurosci Ther

Specialties Neurology
Pharmacology

Date 2024 May 22

PMID 38775149

Authors

Solmaz Fallahi

Hamid Soltani Zangbar

Fereshteh Farajdokht

Reza Rahbarghazi

Gisou Mohaddes

Fariba Ghiasi

Affiliations

Soon will be listed here.

Abstract

Exosomes possess a significant role in intercellular communications. In the nervous system, various neural cells release exosomes that not only own a role in intercellular communications but also eliminate the waste of cells, maintain the myelin sheath, facilitate neurogenesis, and specifically assist in normal cognitive function. In neurological conditions including Parkinson's disease (PD), Alzheimer's disease (AD), traumatic brain injury (TBI), and stroke, exosomal cargo like miRNAs take part in the sequela of conditions and serve as a diagnostic tool of neurological disorders, too. Exosomes are not only a diagnostic tool but also their inhibition or administration from various sources like mesenchymal stem cells and serum, which have shown a worthy potential to treat multiple neurological disorders. In addition to neurodegenerative manifestations, cognitive deficiencies are an integral part of neurological diseases, and applying exosomes in improving both aspects of these diseases has been promising. This review discusses the status of exosome therapy in improving neurorestorative and cognitive function following neurological disease.

Citing Articles

Role of Neural Circuits in Cognitive Impairment.

Zhang L, Liu G, Peng Y, Gao J, Tian M Neurochem Res. 2024; 50(1):49.

PMID: 39644416 DOI: 10.1007/s11064-024-04309-3.

Exosomes as a therapeutic tool to promote neurorestoration and cognitive function in neurological conditions: Achieve two ends with a single effort.

Fallahi S, Zangbar H, Farajdokht F, Rahbarghazi R, Mohaddes G, Ghiasi F CNS Neurosci Ther. 2024; 30(5):e14752.

PMID: 38775149 PMC: 11110007. DOI: 10.1111/cns.14752.

References

Jakubec M, Maple-Grodem J, Akbari S, Nesse S, Halskau O, Mork-Jansson A . Plasma-derived exosome-like vesicles are enriched in lyso-phospholipids and pass the blood-brain barrier. PLoS One. 2020; 15(9):e0232442. PMC: 7505448. DOI: 10.1371/journal.pone.0232442. View

Batool A, Hill T, Nguyen N, Langa E, Diviney M, Mooney C . Altered Biogenesis and MicroRNA Content of Hippocampal Exosomes Following Experimental Status Epilepticus. Front Neurosci. 2020; 13:1404. PMC: 6978807. DOI: 10.3389/fnins.2019.01404. View

Kubota K, Nakano M, Kobayashi E, Mizue Y, Chikenji T, Otani M . An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS One. 2018; 13(9):e0204252. PMC: 6150479. DOI: 10.1371/journal.pone.0204252. View

Gauvreau M, Cote M, Bourgeois-Daigneault M, Rivard L, Xiu F, Brunet A . Sorting of MHC class II molecules into exosomes through a ubiquitin-independent pathway. Traffic. 2009; 10(10):1518-27. DOI: 10.1111/j.1600-0854.2009.00948.x. View

Lajoie J, Shusta E . Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier. Annu Rev Pharmacol Toxicol. 2014; 55:613-31. PMC: 5051266. DOI: 10.1146/annurev-pharmtox-010814-124852. View

Yang Y, Liu Y, Chai Y, Liu K, Hu W, Zhao K . Exosomes in pathogenesis, diagnosis, and treatment of pulmonary fibrosis. Front Pharmacol. 2022; 13:927653. PMC: 9453030. DOI: 10.3389/fphar.2022.927653. View

Dobson R, Giovannoni G . Multiple sclerosis - a review. Eur J Neurol. 2018; 26(1):27-40. DOI: 10.1111/ene.13819. View

Xiong L, Sun L, Zhang Y, Peng J, Yan J, Liu X . Exosomes from Bone Marrow Mesenchymal Stem Cells Can Alleviate Early Brain Injury After Subarachnoid Hemorrhage Through miRNA129-5p-HMGB1 Pathway. Stem Cells Dev. 2019; 29(4):212-221. DOI: 10.1089/scd.2019.0206. View

Reza-Zaldivar E, Hernandez-Sapiens M, Gutierrez-Mercado Y, Sandoval-Avila S, Gomez-Pinedo U, Marquez-Aguirre A . Mesenchymal stem cell-derived exosomes promote neurogenesis and cognitive function recovery in a mouse model of Alzheimer's disease. Neural Regen Res. 2019; 14(9):1626-1634. PMC: 6557105. DOI: 10.4103/1673-5374.255978. View

10.

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

11.

Xia X, Wang Y, Qin Y, Zhao S, Zheng J . Exosome: A novel neurotransmission modulator or non-canonical neurotransmitter?. Ageing Res Rev. 2022; 74:101558. DOI: 10.1016/j.arr.2021.101558. View

12.

Xian P, Hei Y, Wang R, Wang T, Yang J, Li J . Mesenchymal stem cell-derived exosomes as a nanotherapeutic agent for amelioration of inflammation-induced astrocyte alterations in mice. Theranostics. 2019; 9(20):5956-5975. PMC: 6735367. DOI: 10.7150/thno.33872. View

13.

Donoso-Quezada J, Ayala-Mar S, Gonzalez-Valdez J . The role of lipids in exosome biology and intercellular communication: Function, analytics and applications. Traffic. 2021; 22(7):204-220. PMC: 8361711. DOI: 10.1111/tra.12803. View

14.

Heidarzadeh M, Gursoy-Ozdemir Y, Kaya M, Eslami Abriz A, Zarebkohan A, Rahbarghazi R . Exosomal delivery of therapeutic modulators through the blood-brain barrier; promise and pitfalls. Cell Biosci. 2021; 11(1):142. PMC: 8296716. DOI: 10.1186/s13578-021-00650-0. View

15.

Ding G, Li L, Zhang L, Chopp M, Davoodi-Bojd E, Li Q . MRI Metrics of Cerebral Endothelial Cell-Derived Exosomes for the Treatment of Cognitive Dysfunction Induced in Aging Rats Subjected to Type 2 Diabetes. Diabetes. 2022; 71(5):873-880. PMC: 9044132. DOI: 10.2337/db21-0754. View

16.

Ding M, Shen Y, Wang P, Xie Z, Xu S, Zhu Z . Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer's Disease. Neurochem Res. 2018; 43(11):2165-2177. DOI: 10.1007/s11064-018-2641-5. View

17.

Amiri A, Bagherifar R, Dezfouli E, Kiaie S, Jafari R, Ramezani R . Exosomes as bio-inspired nanocarriers for RNA delivery: preparation and applications. J Transl Med. 2022; 20(1):125. PMC: 8919142. DOI: 10.1186/s12967-022-03325-7. View

18.

Kojima K, Amano Y, Yoshino K, Tanaka N, Sugamura K, Takeshita T . ESCRT-0 protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs) is targeted to endosomes independently of signal-transducing adaptor molecule (STAM) and the complex formation with STAM promotes its endosomal dissociation. J Biol Chem. 2014; 289(48):33296-310. PMC: 4246087. DOI: 10.1074/jbc.M114.578245. View

19.

Hauser S, Cree B . Treatment of Multiple Sclerosis: A Review. Am J Med. 2020; 133(12):1380-1390.e2. PMC: 7704606. DOI: 10.1016/j.amjmed.2020.05.049. View

20.

Hood J, Wickline S . A systematic approach to exosome-based translational nanomedicine. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012; 4(4):458-67. DOI: 10.1002/wnan.1174. View